In a study of multiple myeloma, DNA binding activity and induction of osteopontin expression by RUNX2 were reported, which contributed to the proangiogenic effect of RPMI-8226 cells in vitro [26]. This evidence concerns the gene RUNX2 and plasma cell myeloma.